Melting point	101-102 ºC (toluene pentane
Boiling point	265.1±40.0 ºC (760 Tor
Flash point	114.2±27.3 ºC, 计算值*
Density	0.54 g/cm3**

没有数据	没有数据

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

More

Name	CAS

More

Articles

Peer-Reviewed Papers

Fludarabine phosphate in lymphoma: an important new therapeutic agent.P McLaughlin et al.Cancer treatment and research, 85, 3-14 (1996-01-01) Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.Jeannine S McCune et al.Cancer chemotherapy and pharmacology, 75(1), 67-75 (2014-11-07) Fludarabine phosphate in the treatment of chronic lymphocytic leukemia.M J Keating Seminars in oncology, 17(5 Suppl 8), 49-62 (1990-10-01) Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.G Rodriguez Investigational new drugs, 12(2), 75-92 (1994-01-01) Phase I clinical trials with fludarabine phosphate.D D Von Hoff Seminars in oncology, 17(5 Suppl 8), 33-38 (1990-10-01) Fludarabine phosphate: a synthetic purine antimetabolite with significant activity against lymphoid malignancies.H G Chun et al.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 9(1), 175-188 (1991-01-01) Fludarabine phosphate therapy in other lymphoid malignancies.H M Kantarjian et al.Seminars in oncology, 17(5 Suppl 8), 66-70 (1990-10-01) Metabolism and action of fludarabine phosphate.W Plunkett et al.Seminars in oncology, 17(5 Suppl 8), 3-17 (1990-10-01) Issues for the future development of fludarabine phosphate.B D Cheson Seminars in oncology, 17(5 Suppl 8), 71-78 (1990-10-01) Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions.L E Robertson et al.Cancer treatment and research, 64, 105-119 (1993-01-01) Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.J L Binet Nouvelle revue francaise d'hematologie, 35(1), 5-7 (1993-02-01) Fludarabine phosphate: a new active agent in hematologic malignancies.M J Keating et al.Seminars in hematology, 31(1), 28-39 (1994-01-01)

Remarks